Monday, May 12, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

941 POSTS 0 COMMENTS
Alpex BioCleanse, Biotech Stock Review
Superbug News - CoronaVirus Watch List

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now...

Editor / Curator -
American Brivision, Biotech Stock Review
Biotech News

American BriVision (ABVC) Reports Completion Clinical Trial for Treatment of Adult...

Editor / Curator -
Institutional Analyst Newsletter

2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming...

Editor / Curator -
Superbug News - CoronaVirus Watch List

SEC Charges Microcap Fraud Scheme Participants Attempting to Capitalize on the...

Editor / Curator -
American Brivision
Biotech News

Adding American BriVision (ABVC) $3.30 to Stocks We Expect Double List....

Editor / Curator -
Biotech News

Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.

Editor / Curator -
Immuron, Biotech Stock Review
Superbug News - CoronaVirus Watch List

Immuron (IMRN) to Bank $20 Million.

Editor / Curator -
rOBINHOOD tRADER
Research

Robinhood and Robindhoodette.

Editor / Curator -
All News

And Just Like That, We Have Another Double. iBio (IBIO).

Editor / Curator -
Biotech News

Where is Citius Pharma (CTXR) in the FDA Approval Process?

Editor / Curator -
1...656667...95Page 66 of 95

Latest article

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.